Literature DB >> 24172682

Obstructive lung disease is common in children with syndromic and congenital scoliosis: a preliminary study.

Gary L McPhail1, Sacha A Howells, Richard Paul Boesch, Robert E Wood, Mathew Ednick, Barbara A Chini, Viral Jain, Steven Agabegi, Peter Sturm, Eric Wall, Alvin Crawford, Greg Redding.   

Abstract

BACKGROUND: It is well known that restrictive lung disease (RLD) is associated with scoliosis. This study identifies that obstructive lung disease (OLD) is associated with syndromic scoliosis and congenital scoliosis.
METHODS: We searched a local database for patients with scoliosis who underwent a pulmonary function testing (PFT) from 2004 to 2009. All patients with congenital scoliosis or syndromic thoracolumbar scoliosis with a Cobb angle of ≥40 degrees and acceptable and repeatable PFT testing were included in the study. OLD was defined as an forced expiratory volume in the first second/forced vital capacity ratio below 95% confidence interval. Bronchoscopy videos and computed tomography scans or magnetic resonance images were reviewed to identify anatomic causes of lower airway disease.
RESULTS: A total of 18 patients met the criteria for inclusion. The median age at diagnosis was 11.3 years. The median primary Cobb angle was 60 degrees. The prevalence of OLD was 33% and RLD was 57%. The 6 children with OLD underwent preoperative bronchoscopy and chest computed tomography or magnetic resonance imaging to identify anatomic causes of lower airway obstruction. The 4 children with OLD and right-sided major thoracic curves had compression of the right mainstem bronchus between the spine (posterior) and the right pulmonary artery (anterior). The 2 children with OLD and left-sided major thoracic curves had compression of the left mainstem bronchus between the spine (posterior) and the descending aorta (anterior) or the left atrium (anterior).
CONCLUSIONS: In our study, the prevalence of OLD in children with congenital scoliosis or syndromic scoliosis was 33%, which was elevated when compared with the population prevalence of 2% to 5%. Mainstem airway compression from spine rotation was discovered to be the potential mechanism of disease. LEVEL OF EVIDENCE: Level IV, prognostic study investigating the effect of a patient characteristic on the outcome of disease.

Entities:  

Mesh:

Year:  2013        PMID: 24172682     DOI: 10.1097/BPO.0000000000000078

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  6 in total

1.  Neurological complications of thoracic posterior vertebral column resection for severe congenital spinal deformities.

Authors:  Bo-Bo Zhang; Tao Zhang; Hui-Ren Tao; Tai-Lin Wu; Chun-Guang Duan; Wei-Zhou Yang; Tao Li; Feng Li; Ming Liu; Wen-Rui Ma; Wei Su
Journal:  Eur Spine J       Date:  2017-03-31       Impact factor: 3.134

2.  The correlation between spinal and chest wall deformities and pulmonary function in Marfan syndrome.

Authors:  Hila Otremski; Roger F Widmann; Mary F Di Maio; Dror Ovadia
Journal:  J Child Orthop       Date:  2020-08-01       Impact factor: 1.548

3.  Complications associated with surgical repair of syndromic scoliosis.

Authors:  Benjamin J Levy; Jacob F Schulz; Eric D Fornari; Adam L Wollowick
Journal:  Scoliosis       Date:  2015-04-23

4.  Short-term effect and effect on rate of lung function decline after surgery for neuromuscular or syndromic scoliosis.

Authors:  Esther S Veldhoen; Anneloes de Vries; Tom P C Schlosser; Moyo C Kruyt; Ruben P A van Eijk; Joyce M Tersmette; Erik H Hulzebos; Ludo W van der Pol; Roelie M Wösten-van Asperen; Cornelis K van der Ent
Journal:  Pediatr Pulmonol       Date:  2022-02-24

5.  Torsion of left main bronchus during general anesthesia for posterior instrumented spinal fusion.

Authors:  Renuka Arumainathan; Stephen A C Morris; Marina George
Journal:  Clin Case Rep       Date:  2016-05-25

6.  Serial casting in early onset scoliosis: syndromic scoliosis is no contraindication.

Authors:  Tobias M Ballhause; Menard Moritz; Annika Hättich; Ralf Stücker; Kiril Mladenov
Journal:  BMC Musculoskelet Disord       Date:  2019-11-20       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.